Lonza News Oct 27, 2025 Lonza to Acquire Redberry SAS - Contract Pharma #Acquire Redberry #Redberry SAS
Lonza News Oct 27, 2025 Lonza to expand bioscience testing offering with the acquisition of Redberry - Drug Discovery News #Drug Discovery #Redberry Drug
Agilent Oct 27, 2025 Agilent Names Adam S. Elinoff as Chief Financial Officer - Business Wire #Chief Financial #Financial Officer
Agilent Oct 27, 2025 Agilent Technologies Names Adam S. Elinoff as CFO - Yahoo Finance #Yahoo Finance #Agilent Technologies
Thermo Fisher Oct 27, 2025 Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - Business Wire #Enhanced Accelerator #Drug Development
Exscientia Oct 26, 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News - Quiver Quantitative
Schrödinger Oct 25, 2025 Schrödinger (SDGR): Assessing Valuation as AI Innovation Drives New Interest in Biotech - Yahoo Finance
10x Genomics Blog Oct 25, 2025 Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance #Partnership Shift #Competitive Edge
Illumina Oct 25, 2025 Illumina (ILMN): Assessing Valuation After Launch of 5-Base Sequencing and Constellation Platform Advances - Yahoo Finance #Assessing Valuation #Constellation Platform
Roche Media Oct 24, 2025 Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline - Morningstar Canada #Sales Forecast #Slightly Lowering
Lonza News Oct 23, 2025 Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site - Investing.com #Lonza confirms #long-term commercial
Lonza News Oct 23, 2025 Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth - Investing.com #Lonza Group #strong CDMO
Lonza News Oct 23, 2025 Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma #purchased Calif #Lonza recently
Roche Media Oct 23, 2025 Roche axes 4 Chugai solid tumor assets in early-phase clear-out - Fierce Biotech #Chugai solid #Fierce Biotech
Roche Media Oct 23, 2025 China pricing pressure continues to weigh on Roche's diagnostics business - Fierce Biotech #Fierce Biotech #Roche diagnostics
Roche Media Oct 23, 2025 Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track - Fierce Pharma #Fierce Pharma #key medicines